Having established that mice with OXTR deficiency in intestinal epithelium exhibit more advanced colitis and colon cancer (Figs. 1 to 4), we further investigated the role of the OXT system in CAC through OXT supplementation (Fig. S8A). Here, OXTR is linked to malignant colon neoplasm.